TREM2 and metabolic dysfunction-associated steatohepatitis: Recently, single-cell RNA sequencing of human and mouse MASH livers revealed an upregulation of Trem2-expressing macrophages [85], which could serve as a potential treatment target [86], while measuring systemic soluble TREM2 may be a feasible option for non-invasively monitoring MASH severity [87].